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Starting  in 2015,  the  Swedish  government  has  initiated  a national  reform  to standardize
cancer  patient  pathways  and thereby  eventually  speed  up treatment  of  cancer.  Cancer  care
in  Sweden  is characterized  by high  survival  rates  and  a generally  high  quality  albeit  long
waiting  times.  The  objective  with  the  new national  program  to  standardize  cancer  care
pathways  is  to reduce  these  waiting  times,  increase  patient  satisfaction  with cancer  care
and reduce  regional  inequalities.  A new  time-point  for measuring  the  start  of a care  process
is introduced  called  well-founded  suspicion,  which  is  individually  designed  for each  can-
cer diagnosis.  While  medical  guidelines  are well  established  earlier,  the  standardisation  is
achieved  by  deﬁning  time  boundaries  for each  step  in  the  process.  The  cancer  reform  pro-
gram  is a collaborative  effort  initiated  and  incentivized  by  the central  government  whileClinical pathways
Sweden
Waiting list
multi-professional  groups develop  the  time-bound  standardized  care  pathways,  which  the
regional  authorities  are  responsible  for implementing.  The  broad  stakeholder  engagement
and  time-bound  guidelines  are interesting  approaches  to  study  for other  countries  that
need to streamline  care  processes.
© 2016  The  Author(s).  Published  by  Elsevier  Ireland  Ltd.  This  is an open  access  article
under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Swedish health care is characterized by relatively sat-
isfying overall health outcomes, especially in specialized
care. However, long waiting times is a major concern and
an area of underperformance. Waiting times in cancer care
is politically identiﬁed as an arena with unacceptably long
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org/licenses/by-nc-nd/4.0/).waiting times. Therefore, a number of national policies
have over the years been introduced to address this chal-
lenge [1].
The responsibility for health care in Sweden is shared by
the central government, 21 county councils and 290 munic-
ipalities. Traditionally the government’s role has been
legislation, norms setting, evaluation and audit. However,
in recent years agreements between the central govern-
ment and the Swedish Association of Local Authorities
and Regions (SALAR) have become common [2]. These
agreements and associated dialogues represent a form of
national “soft-governing” in Swedish health policy.Swedish cancer care can be described as a divide
between two  sets of outcomes. Survival rates are among
the highest in the world and patient trust in health care
quality is generally satisfying [3,4]. Yet, long waiting times
n access article under the CC BY-NC-ND license (http://creativecommons.
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emain despite a number of policy measures over the years
5,6]. Lack of information and care coordination varies sub-
tantially across diagnoses and geographical regions and
hreaten future outcomes. Thus, there is a persistent dis-
ontent with the lack of accessibility and responsiveness
n large parts of Swedish health care.
In 2009 the Swedish government launched a national
ancer strategy [7] and later (2010) founded six regional
ancer centers working across traditional organisational
oundaries. These cancer centers with mainly central gov-
rnment funding today constitute six well recognized
nowledge hubs for cancer. The centers have developed
upportive activities in collaboration with health care
roviders and the regional health administrations. Because
hey are not responsible for any funding or provision of
ervices, they cannot directly inﬂuence care.
Much of the work and development since the cancer
trategy program [7] was launched in 2009 is seen as
elevant and valuable. Yet, the main objective of shorter
aiting times in cancer care has not been met  [5,6]. Parallel
o the Swedish cancer strategy implementation, Denmark
mbarked on a different program by developing integrated
ancer care pathways (in Danish; pakkeforløb) that go
eyond traditional clinical guidelines of what should be
one for a speciﬁc diagnosis by establishing how many days
ach action needs in the diagnostic and treatment process
f a cancer patient [8].
There were distinctively different starting points for
eform to improve cancer care in Denmark and Sweden.
nlike Sweden, the main problem in Denmark was the
omparatively low cancer survival rates and the perception
hat medical treatment quality was unsatisfactory. The low
urvival rates were thus considered not caused solely by
ife-style and socio-economic factors, but also by a com-
romised quality of care. The Danish integrated cancer
are pathways are considered a success: waiting times has
hortened for the speciﬁc part of the care pathway which
he reform targeted and collaboration between levels of
are has improved [3,4]. Satisfaction with care quality has
lso increased among both patients and staff [8–12].
The Danish experience inﬂuenced the Swedish cen-
ral government to launch Standardized Care Pathways (in
wedish; Standardiserade vårdförlopp) in 2015, based on
he same principles as the Danish reform [8]. The same
ear Norway started a similar program inspired and guided
y Denmark with similar objectives, although at a higher
mplementation speed than planned in Sweden.
. Design of the standardized cancer care pathways
For each cancer diagnosis a set of indications are identi-
ed, and diagnostic procedures and treatment options are
llocated a time frame based on a judgment of what is med-
cally and organisationally possible to detect, diagnose and
reat. The care provider must then hold each “time-slot”,
hich creates a time-bound clinical guideline. When this
s applied to all or a large share of the patients, a standard-
zed care pathway (SCP) is created. Implementation started
015 with ﬁve diagnoses; acute myeloid leukemia, head
nd neck, esophageal and stomach, prostate, and ureteral
nd bladder cancer. These were selected to represent differ-20 (2016) 1378–1382 1379
ent types of treatment processes and had relatively recently
updated traditional medical guidelines.
The model can be designed for the full range or a subset
of a care process. The Swedish SCP is based on a con-
cept called well-founded suspicion designed speciﬁcally for
each cancer diagnosis. Well-founded suspicion is a term
introduced with the reform program and emerges at a point
in time when a set of indicators and test results show a sub-
stantial risk of cancer in either primary or secondary care.
The SCP ends with the start of ﬁrst cancer treatment (Fig. 1).
The general perception of Swedish cancer care is that
once treatment is started, patients are provided with timely
and effective care.
The SCP reform program covers a relatively short section
of the entire process a cancer patient experiences from dis-
ease suspicion and onwards. Still, it involves several care
providers, professions and levels of care that challenges
patient centeredness and integration of services.
For each cancer diagnosis a manual for SCP is developed
nationally by diagnosis speciﬁc multi-professional expert
teams. The SCP manual describes the set of symptoms that
should lead to a suspicion of cancer and requiring further
investigations. It also deﬁnes which symptoms and diag-
nostic results delineate well-founded suspicion of cancer
and specify what the referral to a sub-specialist must con-
tain. Also, the patient must be informed about what will
happen next and within which time-frame she can expect
each further step.
The SCP manual also speciﬁes waiting time for a spe-
cialist appointment, time required for each described
diagnostic procedure prior to treatment, time needed for
pathological and other analysis and a multidisciplinary
meeting. The total number of days from well-founded sus-
picion of cancer to start of ﬁrst treatment is deﬁned by the
total number of days for each step and constitutes the total
target time for the diagnosis.
The graph (Fig. 2) displays waiting times to start of treat-
ment for invasive ureteral and bladder cancer for each of
the 21 Swedish counties in 2014. The graph shows that for
ureteral and bladder cancer, no county could provide even
25% of its patients care within the new SCP target time goal.
The ﬁgure shows a signiﬁcant variation between and within
counties [13].
3. Stakeholders are actively involved in
implementation
The cancer SCP reform program was  initiated by the
Swedish central government (Ministry of Social Affairs),
but SALAR, the Regional Cancer Centres, each region, and
patients’ representatives are together responsible for the
design and implementation of the program. The process
is complemented by a continuing dialogue between the
Ministry and the implementing bodies. Less formal actors
are the diagnosis-speciﬁc multi-professional teams that
supply the necessary medical knowledge and represent
the care professions. The cancer SCPs are thus developed
by medical specialists and multi-professional care teams,
and thereby ﬂips the top–down initiative into a reform
which is designed bottom–up. This is similar to the Danish
integrated cancer care pathways reform, with all stake-
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e standFig. 1. Illustration of th
holders given a chance to inﬂuence the design. The Swedish
National Board of Health and Welfare has been assigned
to monitor and evaluate the cancer SCPs and has for this
purpose formed an expert group with a broad range of
expertise, e.g. in improvement sciences and quality assess-
ment, clinicians and patient representatives.
In addition to a central agreement with SALAR, the 21
independent Swedish counties are incentivized to imple-
ment the reform with a national grant of two billion
Swedish kronor over four years. This is equivalent to
approximately 23 D per capita which likely is of a more
symbolic nature. More important factors for a successful
outcome of the program are e.g. a widespread consensus
of its priority, and the medical professions’ engagement.
All counties have met  the requirements stipulated for the
incentive scheme during the ﬁrst year of reform. If effective,
the central government this way stimulates the reorgani-
sation of health services in cancer care with relatively small
additional resources.
4. Anticipated effects
There are three objectives of the cancer SCP program.
A shorter waiting time to start of ﬁrst treatment is the
most signiﬁcant. The reform has been named the new wait-
ing time reform and by the government given the motto
Each Day Counts!  A second explicit objective is increased
patient satisfaction with cancer care. Patients should be
better informed and more involved in their own care pro-
cess. The third objective is increased equity in cancer care.
The interpretation of this objective is vague in the policy
documents. In the Swedish policy debate it is most often
interpreted as decreased geographical waiting times vari-ardized care pathway.
ation, even though this is a narrow deﬁnition of equity. As
indicated by Fig. 2, this is a well-documented underperfor-
mance of the Swedish health system.
In the longer perspective the cancer SCP reform is also
expected to have an impact on other health services than
cancer care. With more standardized pathways for cancer
patients, the health system as a whole can be expected to
learn and build new and more streamlined ways of work-
ing, and achieve higher efﬁciency.
5. Challenges to the approach
The cancer SCP reform program is targeting several well
recognized problems and there is a broad consensus about
the need to standardize health care services. But a set of
challenges have also been brought forward in the initial
phase of designing the reform.
A basic assumption behind the SCP is that cancer diag-
nostics is a linear process in which patients all need the
same services in the same order, which enables providers
to apply a production logic matching this process. The Dan-
ish experience shows that this is possible for a majority
of cancer patients [8], even though it is probably more
difﬁcult when moving from diagnostics to treatment. To
frail patients and patients with considerable comorbid-
ity, it is more difﬁcult to apply the same standardized
pathway. There is also a trade-off between how fast and
how accurate diagnostic procedures can be conducted.
For hard-to-diagnose patients, a longer time frame can be
frustrating, but might be necessary to provide the best
treatment.
Another potential challenge is crowding out effects and
issues related to horizontal priorities. An example of a
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rowding out effects that needs to be monitored is that
f other cancer patients who are in a later stage of the
are pathway. For example, in combination with a short-
ge of urologists, focus on the early part of the pathway
or prostate cancer patients might lead to prioritizing out-
atient diagnostic services over hospital treatment.
As a result of the focus on cancer, patients with
ther diseases might experience a lower priority. For
xample, pre-booked time slots for diagnostic cancer
ests might affect other patients groups. Thus, there is
 need to continuously increase awareness about issues
elated to horizontal priorities in order to effectively avoid
nintended effects, thus making sure that the Swedish
uidelines and the so called ethical platform guiding med-
cal prioritization, are adequately respected and taken into
ccount [1].
A third challenging area is the need for more integrated
are models. Different health care providers will need toeral and bladder cancer, all Swedish counties.
work together more closely for the cancer SCP reform to
be successful. The above described manuals for SCP have
clearly described at what stage in the diagnostic pathway
the GP shall refer the patient to a specialist. This clariﬁes, at
least in theory, which investigations should be conducted
when and where. But to what extent this will work or how
fast it will be implemented in practice is yet to be seen.
Different groups of specialists might have different views
of who should do what in the diagnostic process, based on
their professional experience.
There are also large structural regional differences
across the country with respect to the role of primary health
care (PHC). In rural areas PHC traditionally have a larger
responsibility for basic diagnostic and health care services.
The structural differences might also play a part in the
interface between out-patient specialist services and hos-
pital services, since the former is much more common in
urban areas.
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Furthermore, a parallel reform process to concentrate
advanced hospital services to fewer geographical locations
is taking place in Sweden, which also requires new clinical
routines. It is argued that with 21 independent counties,
many services including cancer treatments are provided in
too many places to keep medical skills and efﬁciency on
high levels.
6. Conclusions
Starting in early 2015 with ﬁve cancer diagnoses,
Sweden has embarked on a nationwide program to stan-
dardize cancer patient pathways. In 2016 and 2017 the
cancer SCP effort will be covering almost all cancer diag-
noses. The prospects for nationwide impact, in spite of the
strongly decentralized system, looks promising due to a
broad stakeholder engagement: The county councils are
incentivized with a relatively marginal budget support and
the different professions in cancer care are invited to work
out the details of the reform. The new multi stakeholder
approach to standardising by time-bound guidelines may
be useful for other countries and jurisdictions to learn from.
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